drugset / Trial / NCT02156544
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
RandomizedDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety/tolerability and pharmacokinetics/pharmacodynamics of CKD-519.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-10
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ROCACETRAPIB | Small molecule | 25 mg | Oral |
| Subject | ROCACETRAPIB | Small molecule | 50 mg | Oral |
| Subject | ROCACETRAPIB | Small molecule | 100 mg | Oral |
| Subject | ROCACETRAPIB | Small molecule | 200 mg | Oral |
| Subject | ROCACETRAPIB | Small molecule | 400 mg | Oral |